Literature DB >> 21946955

Biochanin A ameliorates the cytokine secretion profile of lipopolysaccharide-stimulated macrophages by a PPARγ-dependent pathway.

Longxin Qiu1, Bo Lin, Zhenzhen Lin, Yiping Lin, Meicong Lin, Xiaoyan Yang.   

Abstract

The role of peroxisome proliferator-activated receptors (PPARs) as anti-inflammatory mediators has been established, and the fact that some isoflavones are dual agonists of PPARα/γ indicates the involvement of PPARα and/or PPARγ in the anti-inflammatory action of certain isoflavones. However, the dependency of isoflavones on PPARs in their anti-inflammatory action has not been demonstrated. Here, we report the dependency of an isoflavone biochanin A and the independency of another isoflavone genistein in relation to PPARγ to ameliorate the cytokine secretion profile of lipopolysaccharide (LPS)-stimulated mouse RAW264.7 macrophages. A total amount of 10 µmol/l of biochanin A or genistein significantly suppressed the secretion of tumor necrosis factor α (TNFα) and interleukin-6 (IL-6) in LPS-induced RAW264.7 cells, whereas another two isoflavones, formononectin and daidzein, only significantly suppressed the secretion of IL-6. Their anti-inflammatory efficiencies were not in correspondence with their PPARα/γ agonist activities. Inhibition of PPARγ activity by its antagonist GW9662 significantly reversed the anti-inflammatory effect of biochanin A but not genistein, which demonstrated the dependency of biochanin A and the independency of genistein on PPARγ in their anti-inflammatory actions. Meanwhile, the PPARγ-dependency of biochanin A was further confirmed by the result that the suppression of LPS-induced NF-κB activation by biochanin A was reversed following GW9662 co-treatment. Moreover, inhibition of PPARα activity by its antagonist MK886 did not significantly reverse the anti-inflammatory effects of biochanin A and genistein, indicating that their anti-inflammatory properties were PPARα-independent.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21946955     DOI: 10.3892/mmr.2011.599

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  8 in total

Review 1.  Novel insights into the mechanisms whereby isoflavones protect against fatty liver disease.

Authors:  Long-Xin Qiu; Tong Chen
Journal:  World J Gastroenterol       Date:  2015-01-28       Impact factor: 5.742

2.  Biochanin A attenuates zymosan-induced arthritis in mice similarly to 17-β estradiol: an alternative to hormone replacement therapy?

Authors:  Franciel Batista Felix; Jessica Maria Dantas Araújo; Elindayane Vieira de Souza; Vanessa Pinho; Enilton Aparecido Camargo; Cristiane Bani Corrêa; Renata Grespan
Journal:  Inflamm Res       Date:  2020-09-25       Impact factor: 4.575

3.  Biochanin A inhibits lipopolysaccharide-induced inflammatory cytokines and mediators production in BV2 microglia.

Authors:  Yang Zhang; Wei-An Chen
Journal:  Neurochem Res       Date:  2014-11-29       Impact factor: 3.996

4.  MLK3 is a direct target of biochanin A, which plays a role in solar UV-induced COX-2 expression in human keratinocytes.

Authors:  Tae-Gyu Lim; Jong-Eun Kim; Sung Keun Jung; Yan Li; Ann M Bode; Jun-Seong Park; Myeong Hun Yeom; Zigang Dong; Ki Won Lee
Journal:  Biochem Pharmacol       Date:  2013-08-12       Impact factor: 5.858

5.  The Dietary Isoflavone Daidzein Reduces Expression of Pro-Inflammatory Genes through PPARα/γ and JNK Pathways in Adipocyte and Macrophage Co-Cultures.

Authors:  Yuri Sakamoto; Junko Kanatsu; Mariko Toh; Ayano Naka; Kazuo Kondo; Kaoruko Iida
Journal:  PLoS One       Date:  2016-02-22       Impact factor: 3.240

Review 6.  Therapeutic potential of PPARγ natural agonists in liver diseases.

Authors:  Liwei Wu; Chuanyong Guo; Jianye Wu
Journal:  J Cell Mol Med       Date:  2020-02-07       Impact factor: 5.310

7.  Red clover extract exerts antidiabetic and hypolipidemic effects in db/db mice.

Authors:  Longxin Qiu; Tong Chen; Fojin Zhong; Yamin Hong; Limei Chen; Hong Ye
Journal:  Exp Ther Med       Date:  2012-08-09       Impact factor: 2.447

8.  Biochanin A extirpates the epithelial-mesenchymal transition in a human lung cancer.

Authors:  Yan Wang; Jiao-Jiao Li; Yu-Min Chen
Journal:  Exp Ther Med       Date:  2018-01-10       Impact factor: 2.447

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.